Back to today’s briefing

Story perspectives

Revolutionary Gene Therapy Targets Alzheimer’s, Shows Promise

6/6/2025

43 9

Summary

Story summary

A groundbreaking gene therapy for Alzheimer’s disease has emerged from UC San Diego School of Medicine, aiming to tackle the disease at its core by modifying brain cell behavior. In promising mouse studies, the therapy not only preserved memory but also changed gene expression. While human trials are on the horizon, Eikonoklastes Therapeutics has already secured FDA Orphan Drug Designation for ALS, paving the way for future innovations.

1 of 1

Story summary

A groundbreaking gene therapy for Alzheimer’s disease has emerged from UC San Diego School of Medicine, aiming to tackle the disease at its core by modifying brain cell behavior. In promising mouse studies, the therapy not only preserved memory but also changed gene expression. While human trials are on the horizon, Eikonoklastes Therapeutics has already secured FDA Orphan Drug Designation for ALS, paving the way for future innovations.